Muscle ultrasound in the assessment of oxaliplatin-induced neurotoxicity

Clin Neurophysiol. 2020 Jan;131(1):343-344. doi: 10.1016/j.clinph.2019.10.001. Epub 2019 Oct 24.

Authors

Luciana Pelosi¹, Catherine H Han², Mark J McKeage²

Affiliations

¹ Department of Neurology, Auckland District Health Board, Auckland Hospital, New Zealand. Electronic address: pelosiluciana@gmail.com.
² Dept. of Pharmacology and Clinical Pharmacology and Auckland Cancer Society Research Centre, University of Auckland, New Zealand; Auckland Cancer Society Research Centre, University of Auckland, New Zealand.

PMID: 31706720
DOI: 10.1016/j.clinph.2019.10.001

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Colorectal Neoplasms / drug therapy
Electromyography / methods
Humans
Male
Muscle, Skeletal / diagnostic imaging*
Muscle, Skeletal / physiopathology
Neurotoxicity Syndromes / diagnostic imaging*
Neurotoxicity Syndromes / physiopathology
Oxaliplatin / adverse effects*
Ultrasonography / methods*
Vibration

Substances

Antineoplastic Agents
Oxaliplatin